Cargando…
Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target
Acute myocardial infarction (AMI) is the single leading cause of mortality and morbidity worldwide. A key component of AMI therapy is the timely reopening of occluded vessels to prevent further ischaemic damage to the myocardium. However, reperfusion of the ischaemic myocardium can itself trigger re...
Autores principales: | Ziegler, Melanie, Wang, Xiaowei, Peter, Karlheinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529900/ https://www.ncbi.nlm.nih.gov/pubmed/30906948 http://dx.doi.org/10.1093/cvr/cvz070 |
Ejemplares similares
-
Putative therapeutic impacts of cardiac CTRP9 in ischaemia/reperfusion injury
por: Sadat‐Ebrahimi, Seyyed‐Reza, et al.
Publicado: (2022) -
Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective
por: Murray, Eleanor C, et al.
Publicado: (2021) -
Mitochondrial mechanisms and therapeutics in ischaemia reperfusion injury
por: Martin, Jack L., et al.
Publicado: (2018) -
Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization
por: Zhao, Jinxuan, et al.
Publicado: (2019) -
The creatine kinase system as a therapeutic target for myocardial ischaemia–reperfusion injury
por: Cao, Fang, et al.
Publicado: (2018)